Correvio Pharma Corp. Net Income
Correvio Pharma Corp. reported Net Income of -$35.18 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2020-04-30
| Period end | Net Income (Loss) Attributable to Parent 12 month |
|---|---|
| 2019-12-31 | -$35.18M 20-F · filed 2020-04-30 |
| 2018-12-31 | -$16.58M 20-F · filed 2020-04-30 |
| 2017-12-31 | -$29.81M 20-F · filed 2020-04-30 |
| 2016-12-31 | -$19.62M 20-F · filed 2018-04-30 |
| 2015-12-31 | -$24.46M 20-F · filed 2018-04-30 |
| 2014-12-31 | -$18.23M 40-F · filed 2016-03-29 |
| 2013-12-31 | $4.77M 40-F · filed 2015-03-27 |
| 2012-12-31 | -$18.32M 40-F/A · filed 2014-04-30 |
| 2011-12-31 | -$27.92M 20-F/A · filed 2013-04-18 |
| 2010-12-31 | $35.50M 20-F/A · filed 2013-04-18 |